{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T11:18:36Z","timestamp":1740136716735,"version":"3.37.3"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,10,18]],"date-time":"2023-10-18T00:00:00Z","timestamp":1697587200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,10,18]],"date-time":"2023-10-18T00:00:00Z","timestamp":1697587200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100003243","name":"Ministerstvo Zdravotnictv\u00ed Cesk\u00e9 Republiky","doi-asserted-by":"publisher","award":["RVO 00023728","RVO 00023728","RVO 00023728","RVO 00023728","RVO 00023728","RVO 00023728","NU22-01-00465"],"award-info":[{"award-number":["RVO 00023728","RVO 00023728","RVO 00023728","RVO 00023728","RVO 00023728","RVO 00023728","NU22-01-00465"]}],"id":[{"id":"10.13039\/501100003243","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arthritis Res Ther"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Objectives<\/jats:title>\n                <jats:p>IL-37 is an anti-inflammatory cytokine involved in inflammatory and autoimmune diseases. We aimed to investigate the association between IL-37 genetic variants, IL-37 plasma levels, and various clinical phases of gout.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>The study included a control group with no history of primary hyperuricemia\/gout, (<jats:italic>n<\/jats:italic>\u2009=\u200950), asymptomatic hyperuricemia (<jats:italic>n<\/jats:italic>\u2009=\u200974), intercritical gout (<jats:italic>n<\/jats:italic>\u2009=\u2009200), acute gouty flare (<jats:italic>n<\/jats:italic>\u2009=\u200918), and chronic tophaceous gout (<jats:italic>n<\/jats:italic>\u2009=\u200930). Plasma IL-37 was analysed using enzyme-linked immunosorbent assay. All coding regions and intron\u2013exon boundaries of IL-37 and exons 1\u20135 were amplified and sequenced.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Plasma levels of IL-37 were significantly higher in asymptomatic hyperuricemic (<jats:italic>p<\/jats:italic>\u2009=\u20090.045), intercritical gout (<jats:italic>p<\/jats:italic>\u2009=\u20090.001), and chronic tophaceous gout (<jats:italic>p<\/jats:italic>\u2009=\u20090.021) cohorts when compared to control group. The levels of IL-37 in patients with acute gouty flare were comparable to control group (<jats:italic>p<\/jats:italic>\u2009=\u20090.061). We identified 15 genetic variants of IL-37: eight intron (rs2708959, rs2723170, rs2708958, rs2723169 rs2466448, rs3811045, rs3811048, rs2708944) and seven non-synonymous allelic variants (rs3811046, rs3811047, rs2708943, rs2723183, rs2723187, rs2708947, rs27231927), of which rs2708959 showed an over-presentation in gouty and acute flare cohorts (<jats:italic>p<\/jats:italic>\u2009=\u20090.003 and 0.033, respectively) compared to European population (minor allelic frequency MAF\u2009=\u20090.05) but not in control and hyperuricemic cohorts (p\/MAF\u2009=\u20090.17\/0.08 and 0.71\/0.05, respectively).. On the contrary, rs3811045, rs3811046, rs3811047, and rs3811048 were underrepresented among individuals with tophaceous gout (MAF\u2009=\u20090.57) compared to European MAF 0.70\u20130.71, but not compared to the control cohort (MAF\u2009=\u20090.67).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>We demonstrated the up-regulation of IL-37 levels across the clinical phases of gout: asymptomatic hyperuricemia, intercritical, and chronic tophaceous gout compared to control. Moreover, 15 genetic variants of IL-37 were identified and their associations with the clinical variants of gout were evaluated.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13075-023-03188-3","type":"journal-article","created":{"date-parts":[[2023,10,18]],"date-time":"2023-10-18T05:01:40Z","timestamp":1697605300000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Interleukin-37: associations of plasma levels and genetic variants in gout"],"prefix":"10.1186","volume":"25","author":[{"given":"Lucie","family":"Andres Cerezo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ad\u00e9la","family":"Navr\u00e1tilov\u00e1","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hana","family":"Hulejov\u00e1","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark\u00e9ta","family":"Pavl\u00edkov\u00e1","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jakub","family":"Z\u00e1vada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karel","family":"Pavelka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ladislav","family":"\u0160enolt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Blanka","family":"Stiburkova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,10,18]]},"reference":[{"key":"3188_CR1","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1038\/s41572-019-0115-y","volume":"5","author":"N Dalbeth","year":"2019","unstructured":"Dalbeth N, Choi HK, Joosten LAB, Khanna PP, Matsuo H, Perez-Ruiz F, et al. Gout Nat Rev Dis Primers. 2019;5:69.","journal-title":"Gout Nat Rev Dis Primers"},{"key":"3188_CR2","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1136\/annrheumdis-2017-212288","volume":"77","author":"N Dalbeth","year":"2018","unstructured":"Dalbeth N, Phipps-Green A, Frampton C, Neogi T, Taylor WJ, Merriman TR. Relationship between serum urate concentration and clinically evident incident gout: an individual participant data analysis. Ann Rheum Dis. 2018;77:1048\u201352.","journal-title":"Ann Rheum Dis"},{"key":"3188_CR3","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbspin.2020.105092","volume":"88","author":"V Kl\u00fcck","year":"2021","unstructured":"Kl\u00fcck V, Liu R, Joosten LAB. The role of interleukin-1 family members in hyperuricemia and gout. Joint Bone Spine. 2021;88: 105092.","journal-title":"Joint Bone Spine"},{"key":"3188_CR4","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1111\/imr.12605","volume":"281","author":"G Cavalli","year":"2018","unstructured":"Cavalli G, Dinarello CA. Suppression of inflammation and acquired immunity by IL-37. Immunol Rev. 2018;281:179\u201390.","journal-title":"Immunol Rev"},{"key":"3188_CR5","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/s12967-015-0394-3","volume":"13","author":"B Chen","year":"2015","unstructured":"Chen B, Huang K, Ye L, Li Y, Zhang J, Zhang J, et al. Interleukin-37 is increased in ankylosing spondylitis patients and associated with disease activity. J Transl Med. 2015;13:36.","journal-title":"J Transl Med"},{"key":"3188_CR6","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1186\/1479-5876-12-69","volume":"12","author":"L Ye","year":"2014","unstructured":"Ye L, Ji L, Wen Z, Zhou Y, Hu D, Li Y, et al. IL-37 inhibits the production of inflammatory cytokines in peripheral blood mononuclear cells of patients with systemic lupus erythematosus: its correlation with disease activity. J Transl Med. 2014;12:69.","journal-title":"J Transl Med"},{"key":"3188_CR7","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1111\/1756-185X.13539","volume":"22","author":"ZC Yuan","year":"2019","unstructured":"Yuan ZC, Wang JM, Huang AF, Su LC, Li SJ, Xu WD. Elevated expression of interleukin-37 in patients with rheumatoid arthritis. Int J Rheum Dis. 2019;22:1123\u20139.","journal-title":"Int J Rheum Dis"},{"key":"3188_CR8","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1038\/ni.1944","volume":"11","author":"MF Nold","year":"2010","unstructured":"Nold MF, Nold-Petry CA, Zepp JA, Palmer BE, Bufler P, Dinarello CA. IL-37 is a fundamental inhibitor of innate immunity. Nat Immunol. 2010;11:1014\u201322.","journal-title":"Nat Immunol"},{"key":"3188_CR9","doi-asserted-by":"publisher","first-page":"2251","DOI":"10.1007\/s10067-015-3109-5","volume":"35","author":"M Zeng","year":"2016","unstructured":"Zeng M, Dang W, Chen B, Qing Y, Xie W, Zhao M, et al. IL-37 inhibits the production of pro-inflammatory cytokines in MSU crystal-induced inflammatory response. Clin Rheumatol. 2016;35:2251\u20138.","journal-title":"Clin Rheumatol"},{"key":"3188_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.cyto.2021.155468","volume":"141","author":"L Ding","year":"2021","unstructured":"Ding L, Li H, Sun B, Wang T, Meng S, Huang Q, et al. Elevated interleukin-37 associated with tophus and pro-inflammatory mediators in Chinese gout patients. Cytokine. 2021;141: 155468.","journal-title":"Cytokine"},{"key":"3188_CR11","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1186\/s13075-016-1167-y","volume":"18","author":"L Liu","year":"2016","unstructured":"Liu L, Xue Y, Zhu Y, Xuan D, Yang X, Liang M, et al. Interleukin 37 limits monosodium urate crystal-induced innate immune responses in human and murine models of gout. Arthritis Res Ther. 2016;18:268.","journal-title":"Arthritis Res Ther"},{"key":"3188_CR12","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1136\/annrheumdis-2019-216233","volume":"79","author":"V Kl\u00fcck","year":"2020","unstructured":"Kl\u00fcck V, van Deuren RC, Cavalli G, Shaukat A, Arts P, Cleophas MC, et al. Rare genetic variants in interleukin-37 link this anti-inflammatory cytokine to the pathogenesis and treatment of gout. Ann Rheum Dis. 2020;79:536\u201344.","journal-title":"Ann Rheum Dis"},{"key":"3188_CR13","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1002\/art.1780200320","volume":"20","author":"SL Wallace","year":"1977","unstructured":"Wallace SL, Robinson H, Masi AT, Decker JL, McCarty DJ, Y\u00fc TF. Preliminary criteria for the classification of the acute arthritis of primary gout. Arthritis Rheum. 1977;20:895\u2013900.","journal-title":"Arthritis Rheum"},{"key":"3188_CR14","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.cca.2011.08.038","volume":"413","author":"B Stiburkova","year":"2012","unstructured":"Stiburkova B, Krijt J, Vyletal P, Bartl J, Gerhatova E, Korinek M, et al. Novel mutations in xanthine dehydrogenase\/oxidase cause severe hypouricemia: biochemical and molecular genetic analysis in two Czech families with xanthinuria type I. Clin Chim Acta. 2012;413:93\u20139.","journal-title":"Clin Chim Acta"},{"key":"3188_CR15","doi-asserted-by":"publisher","first-page":"363","DOI":"10.3390\/cells8040363","volume":"8","author":"Y Toyoda","year":"2019","unstructured":"Toyoda Y, Man\u010d\u00edkov\u00e1 A, Krylov V, Morimoto K, Pavelcov\u00e1 K, Bohat\u00e1 J, et al. Functional characterization of clinically-relevant rare variants in ABCG2 identified in a gout and hyperuricemia cohort. Cells. 2019;8:363.","journal-title":"Cells"},{"key":"3188_CR16","doi-asserted-by":"publisher","first-page":"2510","DOI":"10.3390\/jcm9082510","volume":"9","author":"K Pavelcova","year":"2020","unstructured":"Pavelcova K, Bohata J, Pavlikova M, Bubenikova E, Pavelka K, Stiburkova B. Evaluation of the influence of genetic variants of SLC2A9 (GLUT9) and SLC22A12 (URAT1) on the development of hyperuricemia and gout. J Clin Med. 2020;9:2510.","journal-title":"J Clin Med"},{"key":"3188_CR17","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.708425","volume":"12","author":"DM Santarelli","year":"2021","unstructured":"Santarelli DM, Vincent FB, Rudloff I, Nold-Petry CA, Nold MF, Russo MA. Circulating interleukin-37 levels in healthy adult humans - establishing a reference range. Front Immunol. 2021;12: 708425.","journal-title":"Front Immunol"},{"key":"3188_CR18","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1111\/iji.12007","volume":"40","author":"B Pei","year":"2013","unstructured":"Pei B, Xu S, Liu T, Pan F, Xu J, Ding C. Associations of the IL-1F7 gene polymorphisms with rheumatoid arthritis in Chinese Han population. Int J Immunogenet. 2013;40:199\u2013203.","journal-title":"Int J Immunogenet"},{"key":"3188_CR19","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.cca.2009.10.014","volume":"411","author":"F Pan","year":"2010","unstructured":"Pan F, Liao F, Xia G, Ge R, Mei Y, Tang X, et al. Association of IL-1F7 gene with susceptibility to human leukocyte antigen-B27 positive ankylosing spondylitis in Han Chinese population. Clin Chim Acta. 2010;411:124\u20136.","journal-title":"Clin Chim Acta"},{"key":"3188_CR20","doi-asserted-by":"publisher","first-page":"2281","DOI":"10.1007\/s11033-010-0359-9","volume":"38","author":"R Ge","year":"2011","unstructured":"Ge R, Pan F, Liao F, Xia G, Mei Y, Shen B, et al. Analysis on the interaction between IL-1F7 gene and environmental factors on patients with ankylosing spondylitis: a case-only study. Mol Biol Rep. 2011;38:2281\u20134.","journal-title":"Mol Biol Rep"},{"key":"3188_CR21","doi-asserted-by":"crossref","unstructured":"Ahmed AA, Ad\u2019hiah AH. Interleukin-37 gene polymorphism and susceptibility to coronavirus disease 19 among Iraqi patients. Meta Gene. 2022;31:100989.","DOI":"10.1016\/j.mgene.2021.100989"},{"key":"3188_CR22","doi-asserted-by":"crossref","unstructured":"Ali ZA, Mankhi AA, Ad\u2019hiah AH. Interleukin-37 gene polymorphism and susceptibility to pulmonary tuberculosis among Iraqi patients. Indian J Tuberc. 2022;69:191\u2013200.","DOI":"10.1016\/j.ijtb.2021.08.003"},{"key":"3188_CR23","doi-asserted-by":"publisher","first-page":"171","DOI":"10.4103\/0366-6999.222340","volume":"131","author":"XY Zhang","year":"2018","unstructured":"Zhang XY, Zuo Y, Li C, Tu X, Xu HJ, Guo JP, et al. IL1F7 gene polymorphism is not associated with rheumatoid arthritis susceptibility in the Northern Chinese Han population: a case-control study. Chin Med J (Engl). 2018;131:171\u20139.","journal-title":"Chin Med J (Engl)"},{"key":"3188_CR24","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1089\/gtmb.2015.0344","volume":"20","author":"S Mookherjee","year":"2016","unstructured":"Mookherjee S, Banerjee D, Chakraborty S, Mukhopadhyay I, Sen A, Ray K. Evaluation of the IL1 gene cluster single nucleotide polymorphisms in primary open-angle glaucoma pathogenesis. Genet Test Mol Biomarkers. 2016;20:633\u20136.","journal-title":"Genet Test Mol Biomarkers"},{"key":"3188_CR25","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1080\/08830185.2019.1677644","volume":"39","author":"G Allam","year":"2020","unstructured":"Allam G, Gaber AM, Othman SI, Abdel-Moneim A. The potential role of interleukin-37 in infectious diseases. Int Rev Immunol. 2020;39:3\u201310.","journal-title":"Int Rev Immunol"},{"key":"3188_CR26","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1002\/JPER.20-0126","volume":"92","author":"T Cirelli","year":"2021","unstructured":"Cirelli T, Nepomuceno R, Orrico SRP, Rossa C Jr, Cirelli JA, North KE, et al. Validation in a Brazilian population of gene markers of periodontitis previously investigated by GWAS and bioinformatic studies. J Periodontol. 2021;92:689\u2013703.","journal-title":"J Periodontol"},{"key":"3188_CR27","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1530\/JME-15-0144","volume":"55","author":"N Yan","year":"2015","unstructured":"Yan N, Meng S, Song RH, Qin Q, Wang X, Yao Q, et al. Polymorphism of IL37 gene as a protective factor for autoimmune thyroid disease. J Mol Endocrinol. 2015;55:209\u201318.","journal-title":"J Mol Endocrinol"},{"key":"3188_CR28","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000010386","volume":"97","author":"XY Lin","year":"2018","unstructured":"Lin XY, Guo XJ, He YZ, Hou SF, Zhu HB, Cheng Y, et al. Association between interleukin 37 (rs3811047) polymorphism and multiple autoimmune diseases in a Chinese population: a PRISMA-compliant meta-analysis. Medicine (Baltimore). 2018;97: e0386.","journal-title":"Medicine (Baltimore)"}],"container-title":["Arthritis Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-023-03188-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13075-023-03188-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-023-03188-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,20]],"date-time":"2023-11-20T10:47:33Z","timestamp":1700477253000},"score":1,"resource":{"primary":{"URL":"https:\/\/arthritis-research.biomedcentral.com\/articles\/10.1186\/s13075-023-03188-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,18]]},"references-count":28,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["3188"],"URL":"https:\/\/doi.org\/10.1186\/s13075-023-03188-3","relation":{},"ISSN":["1478-6362"],"issn-type":[{"type":"electronic","value":"1478-6362"}],"subject":[],"published":{"date-parts":[[2023,10,18]]},"assertion":[{"value":"6 April 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 October 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 October 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Written informed consent was obtained from each subject, and all tests were performed according to standards set by the local Ethics Committee of the Institute of Rheumatology in Prague, Czech Republic (project no. 6181\/2015).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"203"}}